bioRxiv/medRxiv TRiP Review Activity

413 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 27: Articles 261-270  | Next

Heterogeneity of the Cancer Cell Line Metabolic Landscape
Shorthouse, D., Bradley, J., Critchlow, S., Bendtsen, C., Hall, B. A.
10.1101/2021.08.19.456093 — Posted: 2021-08-19 — Discussion: 2022-11-21  EMBO Press
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Meister, M. T., Groot Koerkamp, M. J. A., de Souza, T., Breunis, W. B., Frazer-Mendelewska, E., Brok, M., DeMartino, J., Manders, F., Calandrini, C., Kerstens, H. H. D., Janse, A., Dolman, M. E. M., Eising, S., Langenberg, K. P. S., van Tuil, M., Knops, R. R. G., Terwisscha van Scheltinga, S., Hiemcke-Jiwa, L. S., Flucke, U., Merks, J. H. M., van Noesel, M. M., Tops, B. B. J., Hehir-Kwa, J. Y., Kemmeren, P., Molenaar, J. J., van de Wetering, M., van Boxtel, R., Drost, J., Holstege, F. C. P.
10.1101/2022.01.03.474504 — Posted: 2022-01-04 — Discussion: 2022-11-21  EMBO Press
Low HER2 enables dedifferentiation and transformation of normal breast epithelial cells via chromatin opening
Hayat, A., Carter, E., King, H. W., Ors, A., Doe, A., Teijeiro, S. A., Charrot, S., Godinho, S., Cutillas, P. R., Mohammed, H., Grose, R. P., Ficz, G.
10.1101/2022.09.06.506760 — Posted: 2022-09-06 — Discussion: 2022-11-17  Review Commons
Defining cellular population dynamics at single cell resolution during prostate cancer progression
Germanos, A. A., Arora, S., Zheng, Y., Goddard, E. T., Coleman, I. M., Ku, A. T., Wilkinson, S., Amezquita, R. A., Zager, M., Long, A., Yang, Y. C., Bielas, J. H., Gottardo, R., Ghajar, C. M., Nelson, P. S., Sowalsky, A. G., Setty, M., Hsieh, A. C.
10.1101/2022.03.02.482711 — Posted: 2022-03-04 — Discussion: 2022-11-16  eLife
EZH2/ hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
Lin, Z.-S., Chung, C.-C., Liu, Y.-C., Chang, C.-H., Liu, H.-C., Liang, Y.-Y., Huang, T.-L., Chen, T.-M., Lee, C.-H., Tang, C.-H., Chen, Y.-H., Hung, M.-C.
10.1101/2022.06.07.495151 — Posted: 2022-06-09 — Discussion: 2022-11-07  eLife
WILD-seq: Clonal deconvolution of transcriptomic signatures of sensitivity and resistance to cancer therapeutics in vivo.
Wild, S. A., Cannell, I. G., Kania, K., CRUK IMAXT Grand Challenge Team, , Hannon, G. J., Sawicka, K.
10.1101/2021.12.09.471927 — Posted: 2021-12-10 — Discussion: 2022-11-07  eLife
Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis
Schwager, S. C., Hapach, L. A., Carlson, C. M., Mosier, J. A., McArdle, T. J., Wang, W., Jayathilake, A. L., Bordeleau, F., Antonyak, M. A., Cerione, R. A., Reinhart-King, C. A.
10.1101/2021.10.27.466095 — Posted: 2021-10-29 — Discussion: 2022-11-03  eLife
Co-deletion of ATAD1 with PTEN primes cells for BIM-mediated apoptosis
Winter, J. M., Fresenius, H. L., Keys, H. R., Cunningham, C. N., Ryan, J., Sirohi, D., Berg, J. A., Tripp, S. R., Barta, P., Agarwal, N., Letai, A., Sabatini, D. M., Wohlever, M. L., Rutter, J.
10.1101/2021.07.01.450781 — Posted: 2021-07-03 — Discussion: 2022-11-03  eLife
The Fatty Acid Binding Protein Family Represents a Novel Target in Multiple Myeloma
Farrell, M., Fairfield, H., Karam, M., D'Amico, A., Murphy, C. S., Falank, C., Pistofidi, R. S., Cao, A., Marinac, C. R., Dragon, J. A., McGuinness, L., Gartner, C. G., Iorio, R. D., Jachimowicz, E., DeMambro, V., Vary, C., Reagan, M. R.
10.1101/2022.07.01.498411 — Posted: 2022-07-02 — Discussion: 2022-10-19  eLife
Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer
Fodde, R.
10.1101/2022.03.01.482471 — Posted: 2022-03-01 — Discussion: 2022-10-18  eLife

Evaluation Sources